메뉴 건너뛰기




Volumn 6, Issue , 2015, Pages

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

(313)  Ayton, Scott a   Faux, Noel G a,b   Bush, Ashley I a,b   Weiner, Michael W c   Aisen, Paul d   Petersen, Ronald e   Jack, Clifford R e   Jagust, William f   Trojanowki, John Q g   Toga, Arthur W h   Beckett, Laurel i   Green, Robert C j   Saykin, Andrew J k   Morris, John l   Shaw, Leslie M g   Khachaturian, Zaven d,m   Sorensen, Greg n   Kuller, Lew o   Raichle, Marc l   Paul, Steven p   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; FERRITIN; TAU PROTEIN; UNCLASSIFIED DRUG; IRON;

EID: 84930225631     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7760     Document Type: Article
Times cited : (249)

References (48)
  • 1
    • 84920602939 scopus 로고    scopus 로고
    • 7T T2-weighted magnetic resonance imaging reveals cortical phase differences between early-and late-onset Alzheimer's disease
    • van Rooden, S. et al. 7T T2-weighted magnetic resonance imaging reveals cortical phase differences between early-and late-onset Alzheimer's disease. Neurobiol. Aging 36, 20-26 (2014).
    • (2014) Neurobiol. Aging , vol.36 , pp. 20-26
    • Van Rooden, S.1
  • 2
    • 0030885482 scopus 로고    scopus 로고
    • Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
    • Smith, M. A., Harris, P. L., Sayre, L. M. & Perry, G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866-9868 (1997).
    • (1997) Proc. Natl Acad. Sci. USA , vol.94 , pp. 9866-9868
    • Smith, M.A.1    Harris, P.L.2    Sayre, L.M.3    Perry, G.4
  • 3
    • 0025726462 scopus 로고
    • Intramuscular desferrioxamine in patients with Alzheimer's disease
    • Crapper McLachlan, D. R. et al. Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308 (1991).
    • (1991) Lancet , vol.337 , pp. 1304-1308
    • Crapper McLachlan, D.R.1
  • 4
    • 84856708923 scopus 로고    scopus 로고
    • Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
    • Lei, P. et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291-295 (2012).
    • (2012) Nat. Med. , vol.18 , pp. 291-295
    • Lei, P.1
  • 6
    • 0026513756 scopus 로고
    • A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
    • Connor, J. R., Menzies, S. L., St Martin, S. M. & Mufson, E. J. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83 (1992).
    • (1992) J. Neurosci. Res. , vol.31 , pp. 75-83
    • Connor, J.R.1    Menzies, S.L.2    St Martin, S.M.3    Mufson, E.J.4
  • 7
    • 1842451926 scopus 로고    scopus 로고
    • Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases
    • Bartzokis, G., Tishler, T. A., Shin, I. S., Lu, P. H. & Cummings, J. L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 1012, 224-236 (2004).
    • (2004) Ann. N. Y. Acad. Sci. , vol.1012 , pp. 224-236
    • Bartzokis, G.1    Tishler, T.A.2    Shin, I.S.3    Lu, P.H.4    Cummings, J.L.5
  • 8
    • 29844456397 scopus 로고    scopus 로고
    • Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level
    • Quintana, C. et al. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 153, 42-54 (2006).
    • (2006) J. Struct. Biol. , vol.153 , pp. 42-54
    • Quintana, C.1
  • 9
    • 0033525437 scopus 로고    scopus 로고
    • Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain
    • Hansen, T. M., Nielsen, H., Bernth, N. & Moos, T. Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain. Brain Res. Mol. Brain Res. 65, 186-197 (1999).
    • (1999) Brain Res. Mol. Brain Res. , vol.65 , pp. 186-197
    • Hansen, T.M.1    Nielsen, H.2    Bernth, N.3    Moos, T.4
  • 10
    • 0036220778 scopus 로고    scopus 로고
    • The lipophilic iron compound TMH-ferrocene [(3,5,5-trimethylhexanoyl)ferrocene] increases iron concentrations, neuronal L-ferritin, and heme oxygenase in brains of BALB/c mice
    • Malecki, E. A., Cable, E. E., Isom, H. C. & Connor, J. R. The lipophilic iron compound TMH-ferrocene [(3,5,5-trimethylhexanoyl)ferrocene] increases iron concentrations, neuronal L-ferritin, and heme oxygenase in brains of BALB/c mice. Biol. Trace Elem. Res. 86, 73-84 (2002).
    • (2002) Biol. Trace Elem. Res. , vol.86 , pp. 73-84
    • Malecki, E.A.1    Cable, E.E.2    Isom, H.C.3    Connor, J.R.4
  • 11
    • 33750535445 scopus 로고    scopus 로고
    • Cellular iron status influences the functional relationship between microglia and oligodendrocytes
    • Zhang, X., Surguladze, N., Slagle-Webb, B., Cozzi, A. & Connor, J. R. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54, 795-804 (2006).
    • (2006) Glia , vol.54 , pp. 795-804
    • Zhang, X.1    Surguladze, N.2    Slagle-Webb, B.3    Cozzi, A.4    Connor, J.R.5
  • 12
    • 0034102395 scopus 로고    scopus 로고
    • Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
    • Earley, C. J. et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54, 1698-1700 (2000).
    • (2000) Neurology , vol.54 , pp. 1698-1700
    • Earley, C.J.1
  • 13
    • 0028174385 scopus 로고
    • Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy
    • Kuiper, M. A., Mulder, C., van Kamp, G. J., Scheltens, P. & Wolters, E. C. Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy. J. Neural Transm. Park. Dis. Dement. Sect. 7, 109-114 (1994).
    • (1994) J. Neural Transm. Park. Dis. Dement. Sect. , vol.7 , pp. 109-114
    • Kuiper, M.A.1    Mulder, C.2    Van Kamp, G.J.3    Scheltens, P.4    Wolters, E.C.5
  • 14
    • 79955431733 scopus 로고    scopus 로고
    • Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
    • Craig-Schapiro, R. et al. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PloS ONE 6, e18850 (2011).
    • (2011) PloS ONE , vol.6
    • Craig-Schapiro, R.1
  • 15
    • 84905254120 scopus 로고    scopus 로고
    • Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
    • Paterson, R. W. et al. Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals. Transl. Psychiatry 4, e419 (2014).
    • (2014) Transl. Psychiatry , vol.4 , pp. e419
    • Paterson, R.W.1
  • 16
    • 84889600279 scopus 로고    scopus 로고
    • Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults
    • Mattsson, N. et al. Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. Neurobiol. Aging 35, 614-622 (2014).
    • (2014) Neurobiol. Aging , vol.35 , pp. 614-622
    • Mattsson, N.1
  • 17
    • 67651204382 scopus 로고    scopus 로고
    • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
    • Mattsson, N. et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393 (2009).
    • (2009) JAMA , vol.302 , pp. 385-393
    • Mattsson, N.1
  • 18
    • 0027194791 scopus 로고
    • Gene dose of apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families
    • Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923 (1993).
    • (1993) Science , vol.261 , pp. 921-923
    • Corder, E.H.1
  • 19
    • 84867119124 scopus 로고    scopus 로고
    • Cerebrospinal fluid APOE levels: An endophenotype for genetic studies for Alzheimer's disease
    • Cruchaga, C. et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease. Hum. Mol. Genet. 21, 4558-4571 (2012).
    • (2012) Hum. Mol. Genet. , vol.21 , pp. 4558-4571
    • Cruchaga, C.1
  • 20
    • 84899898187 scopus 로고    scopus 로고
    • Total apolipoprotein e levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
    • Martinez-Morillo, E. et al. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Acta Neuropathol. 127, 633-643 (2014).
    • (2014) Acta Neuropathol. , vol.127 , pp. 633-643
    • Martinez-Morillo, E.1
  • 21
    • 84899905643 scopus 로고    scopus 로고
    • CSF Apo-E levels associate with cognitive decline and MRI changes
    • Toledo, J. B. et al. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol. 127, 621-632 (2014).
    • (2014) Acta Neuropathol. , vol.127 , pp. 621-632
    • Toledo, J.B.1
  • 22
    • 70350532722 scopus 로고    scopus 로고
    • CSF biomarkers predict rate of cognitive decline in Alzheimer disease
    • Kester, M. I. et al. CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology 73, 1353-1358 (2009).
    • (2009) Neurology , vol.73 , pp. 1353-1358
    • Kester, M.I.1
  • 23
    • 0345392666 scopus 로고    scopus 로고
    • Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: Comparison with mild cognitive impairment and normal aging
    • Estevez-Gonzalez, A., Kulisevsky, J., Boltes, A., Otermin, P. & Garcia-Sanchez, C. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging. Int. J. Geriatr. Psychiatry 18, 1021-1028 (2003).
    • (2003) Int. J. Geriatr. Psychiatry , vol.18 , pp. 1021-1028
    • Estevez-Gonzalez, A.1    Kulisevsky, J.2    Boltes, A.3    Otermin, P.4    Garcia-Sanchez, C.5
  • 24
    • 84883116877 scopus 로고    scopus 로고
    • CSF protein biomarkers predicting longitudinal reduction of CSF beta-amyloid42 in cognitively healthy elders
    • Mattsson, N. et al. CSF protein biomarkers predicting longitudinal reduction of CSF beta-amyloid42 in cognitively healthy elders. Transl. Psychiatry 3, e293 (2013).
    • (2013) Transl. Psychiatry , vol.3 , pp. e293
    • Mattsson, N.1
  • 25
    • 77954033982 scopus 로고    scopus 로고
    • 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
    • Apostolova, L. G. et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol. Aging 31, 1284-1303 (2010).
    • (2010) Neurobiol. Aging , vol.31 , pp. 1284-1303
    • Apostolova, L.G.1
  • 26
    • 84897930725 scopus 로고    scopus 로고
    • Targeting chelatable iron as a therapeutic modality in Parkinson's disease
    • Devos, D. et al. Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid. Redox Signal. 21, 195-210 (2014).
    • (2014) Antioxid. Redox Signal. , vol.21 , pp. 195-210
    • Devos, D.1
  • 27
    • 77956647381 scopus 로고    scopus 로고
    • Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
    • Duce, J. A. et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867 (2010).
    • (2010) Cell , vol.142 , pp. 857-867
    • Duce, J.A.1
  • 29
    • 18344414746 scopus 로고    scopus 로고
    • The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
    • Huang, X. et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616 (1999).
    • (1999) Biochemistry , vol.38 , pp. 7609-7616
    • Huang, X.1
  • 30
    • 0036724204 scopus 로고    scopus 로고
    • Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: Implications in the formation of neurofibrillary tangles of Alzheimer's disease
    • Yamamoto, A. et al. Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J. Neurochem. 82, 1137-1147 (2002).
    • (2002) J. Neurochem. , vol.82 , pp. 1137-1147
    • Yamamoto, A.1
  • 31
    • 33846989334 scopus 로고    scopus 로고
    • Adultonset neurodegeneration with brain iron accumulation and cortical alphasynuclein and tau pathology: A distinct clinicopathological entity
    • Tofaris, G. K., Revesz, T., Jacques, T. S., Papacostas, S. & Chataway, J. Adultonset neurodegeneration with brain iron accumulation and cortical alphasynuclein and tau pathology: a distinct clinicopathological entity. Arch. Neurol. 64, 280-282 (2007).
    • (2007) Arch. Neurol. , vol.64 , pp. 280-282
    • Tofaris, G.K.1    Revesz, T.2    Jacques, T.S.3    Papacostas, S.4    Chataway, J.5
  • 32
    • 50049089758 scopus 로고    scopus 로고
    • Hyperphosphorylation of tau protein in superficial CNS siderosis
    • Kondziella, D. & Zetterberg, H. Hyperphosphorylation of tau protein in superficial CNS siderosis. J. Neurol. Sci. 273, 130-132 (2008).
    • (2008) J. Neurol. Sci. , vol.273 , pp. 130-132
    • Kondziella, D.1    Zetterberg, H.2
  • 33
    • 78349309559 scopus 로고    scopus 로고
    • Apolipoprotein e ablation decreases synaptic vesicular zinc in the brain
    • Lee, J. Y. et al. Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain. Biometals 23, 1085-1095 (2010).
    • (2010) Biometals , vol.23 , pp. 1085-1095
    • Lee, J.Y.1
  • 34
    • 0034105453 scopus 로고    scopus 로고
    • Increased levels of intracellular iron in the brains of A poE-deficient mice with closed head injury
    • Lomnitski, L., Nyska, A., Shohami, E., Chen, Y. & Michaelson, D. M. Increased levels of intracellular iron in the brains of A poE-deficient mice with closed head injury. Exp. Toxicol. Pathol. 52, 177-183 (2000).
    • (2000) Exp. Toxicol. Pathol. , vol.52 , pp. 177-183
    • Lomnitski, L.1    Nyska, A.2    Shohami, E.3    Chen, Y.4    Michaelson, D.M.5
  • 35
    • 8644245902 scopus 로고    scopus 로고
    • Secretion of ferritin by iron-laden macrophages and influence of lipoproteins
    • Yuan, X. M., Li, W., Baird, S. K., Carlsson, M. & Melefors, O. Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Radic. Res. 38, 1133-1142 (2004).
    • (2004) Free Radic. Res. , vol.38 , pp. 1133-1142
    • Yuan, X.M.1    Li, W.2    Baird, S.K.3    Carlsson, M.4    Melefors, O.5
  • 36
    • 0028092997 scopus 로고
    • Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms
    • Dong, L. M. et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269, 22358-22365 (1994).
    • (1994) J. Biol. Chem. , vol.269 , pp. 22358-22365
    • Dong, L.M.1
  • 37
    • 84904757635 scopus 로고    scopus 로고
    • HFE gene variants, iron, and lipids: A novel connection in Alzheimer's disease
    • Ali-Rahmani, F., Schengrund, C. L. & Connor, J. R. HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease. Front. Pharmacol. 5, 165 (2014).
    • (2014) Front. Pharmacol. , vol.5 , pp. 165
    • Ali-Rahmani, F.1    Schengrund, C.L.2    Connor, J.R.3
  • 38
    • 84856414697 scopus 로고    scopus 로고
    • The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
    • Weiner, M. W. et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer's Dement. 8, S1-68 (2012).
    • (2012) Alzheimer's Dement. , vol.8 , pp. S1-68
    • Weiner, M.W.1
  • 39
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1
  • 40
    • 79958102380 scopus 로고    scopus 로고
    • Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
    • Shaw, L. M. et al. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol. 121, 597-609 (2011).
    • (2011) Acta Neuropathol. , vol.121 , pp. 597-609
    • Shaw, L.M.1
  • 41
    • 65249159879 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
    • Shaw, L. M. et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 65, 403-413 (2009).
    • (2009) Ann. Neurol. , vol.65 , pp. 403-413
    • Shaw, L.M.1
  • 42
    • 41949137974 scopus 로고    scopus 로고
    • The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
    • Jack, Jr. C. R. et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J. Magn. Reson. Imag. 27, 685-691 (2008).
    • (2008) J. Magn. Reson. Imag. , vol.27 , pp. 685-691
    • Jack, C.R.1
  • 47
    • 84863813315 scopus 로고    scopus 로고
    • Deducer: A data analysis GUI for R
    • Fellows, I. Deducer: a data analysis GUI for R. J. Stat. Softw. 48, 1-15 (2012).
    • (2012) J. Stat. Softw. , vol.48 , pp. 1-15
    • Fellows, I.1
  • 48
    • 0038351884 scopus 로고    scopus 로고
    • Diagnostic capability of CSF ferritin in children with meningitis
    • Kim, Y. O., Kang, J. S., Youm, M. H. & Jong Woo, Y. Diagnostic capability of CSF ferritin in children with meningitis. Pediatr. Neurol. 28, 271-276 (2003).
    • (2003) Pediatr. Neurol. , vol.28 , pp. 271-276
    • Kim, Y.O.1    Kang, J.S.2    Youm, M.H.3    Jong Woo, Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.